177 related articles for article (PubMed ID: 33283432)
21. [Epidemiological characteristics and related influencing factors on Japanese encephalitis in Hainan Province].
Pan XH; Sun LY; Wang CL; Zhu J; Fu ZW; Zeng ZC; Zeng XX; Yan XJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 May; 30(5):471-4. PubMed ID: 19799143
[TBL] [Abstract][Full Text] [Related]
22. Japanese encephalitis vaccine: need of the hour in endemic states of India.
Verma R
Hum Vaccin Immunother; 2012 Apr; 8(4):491-3. PubMed ID: 22370517
[TBL] [Abstract][Full Text] [Related]
23. [A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas].
Zhou B; Jia L; Xu X
Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Feb; 20(1):38-41. PubMed ID: 10682513
[TBL] [Abstract][Full Text] [Related]
24. Japanese Encephalitis Surveillance and Immunization - Asia and Western Pacific Regions, 2016.
Heffelfinger JD; Li X; Batmunkh N; Grabovac V; Diorditsa S; Liyanage JB; Pattamadilok S; Bahl S; Vannice KS; Hyde TB; Chu SY; Fox KK; Hills SL; Marfin AA
MMWR Morb Mortal Wkly Rep; 2017 Jun; 66(22):579-583. PubMed ID: 28594790
[TBL] [Abstract][Full Text] [Related]
25. Hospital-based surveillance for Japanese encephalitis in Bangladesh, 2007-2016: Implications for introduction of immunization.
Paul KK; Sazzad HMS; Rahman M; Sultana S; Hossain MJ; Ledermann JP; Burns P; Friedman MS; Flora MS; Fischer M; Hills S; Luby SP; Gurley ES
Int J Infect Dis; 2020 Oct; 99():69-74. PubMed ID: 32721530
[TBL] [Abstract][Full Text] [Related]
26. Immunization against Japanese encephalitis in China: a policy analysis.
Liu W; Clemens JD; Yang JY; Xu ZY
Vaccine; 2006 Jun; 24(24):5178-82. PubMed ID: 16697091
[TBL] [Abstract][Full Text] [Related]
27. Recommendations for the use of Japanese encephalitis vaccines.
Lee PI; Huang YC; Hwang KP; Liu CC; Chiu CH; Chen PY; Lu CY; Chen CJ; Chang LY; Chiu NC; Chi H; Lin HC; Wu KG; Ho YH; Sun W; Lin TY
Pediatr Neonatol; 2020 Feb; 61(1):3-8. PubMed ID: 31870559
[TBL] [Abstract][Full Text] [Related]
28. Japanese encephalitis in Malaysia: An overview and timeline.
Kumar K; Arshad SS; Selvarajah GT; Abu J; Toung OP; Abba Y; Yasmin AR; Bande F; Sharma R; Ong BL
Acta Trop; 2018 Sep; 185():219-229. PubMed ID: 29856986
[TBL] [Abstract][Full Text] [Related]
29. Serological and molecular epidemiology of Japanese Encephalitis in Zhejiang, China, 2015-2018.
Deng X; Yan JY; He HQ; Yan R; Sun Y; Tang XW; Zhou Y; Pan JH; Mao HY; Zhang YJ; Lv HK
PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008574. PubMed ID: 32853274
[TBL] [Abstract][Full Text] [Related]
30. Japanese encephalitis disease burden and clinical features of Japanese encephalitis in four cities in the People's Republic of China.
Yin Z; Wang H; Yang J; Luo H; Li Y; Hadler SC; Sandhu HS; Fischer M; Jiang Y; Zhang Z; Liu G; Li L; Johnson BW; Liang X;
Am J Trop Med Hyg; 2010 Oct; 83(4):766-73. PubMed ID: 20889863
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology of Japanese encephalitis in South Korea, 2007-2010.
Lee DW; Choe YJ; Kim JH; Song KM; Cho H; Bae GR; Lee JK
Int J Infect Dis; 2012 Jun; 16(6):e448-52. PubMed ID: 22497964
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study.
Bista MB; Banerjee MK; Shin SH; Tandan JB; Kim MH; Sohn YM; Ohrr HC; Tang JL; Halstead SB
Lancet; 2001 Sep; 358(9284):791-5. PubMed ID: 11564484
[TBL] [Abstract][Full Text] [Related]
33. Overview of Japanese encephalitis disease and its prevention. Focus on IC51 vaccine (IXIARO
Amicizia D; Zangrillo F; Lai PL; Iovine M; Panatto D
J Prev Med Hyg; 2018 Mar; 59(1):E99-E107. PubMed ID: 29938245
[TBL] [Abstract][Full Text] [Related]
34. Impact of SA 14-14-2 vaccination on the occurrence of Japanese encephalitis in India.
Muniaraj M; Rajamannar V
Hum Vaccin Immunother; 2019; 15(4):834-840. PubMed ID: 30681400
[TBL] [Abstract][Full Text] [Related]
35. Estimates of Japanese Encephalitis mortality and morbidity: A systematic review and modeling analysis.
Cheng Y; Tran Minh N; Tran Minh Q; Khandelwal S; Clapham HE
PLoS Negl Trop Dis; 2022 May; 16(5):e0010361. PubMed ID: 35613183
[TBL] [Abstract][Full Text] [Related]
36. Current recommendations for the Japanese encephalitis vaccine.
Chen HL; Chang JK; Tang RB
J Chin Med Assoc; 2015 May; 78(5):271-5. PubMed ID: 25841620
[TBL] [Abstract][Full Text] [Related]
37. Japanese encephalitis in mainland china.
Wang H; Li Y; Liang X; Liang G
Jpn J Infect Dis; 2009 Sep; 62(5):331-6. PubMed ID: 19762980
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of the Viet Nam produced, mouse brain-derived, inactivated Japanese encephalitis vaccine in Northern Viet Nam.
Marks F; Nguyen TT; Tran ND; Nguyen MH; Vu HH; Meyer CG; You YA; Konings F; Liu W; Wierzba TF; Xu ZY
PLoS Negl Trop Dis; 2012; 6(12):e1952. PubMed ID: 23272262
[TBL] [Abstract][Full Text] [Related]
39. Cost-effectiveness of Japanese encephalitis (JE) immunization in Bali, Indonesia.
Liu W; Clemens JD; Kari K; Xu ZY
Vaccine; 2008 Aug; 26(35):4456-60. PubMed ID: 18602436
[TBL] [Abstract][Full Text] [Related]
40. Epidemiological situation of Japanese encephalitis in Nepal.
Bista MB; Shrestha JM
JNMA J Nepal Med Assoc; 2005; 44(158):51-6. PubMed ID: 16554872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
